RNA-based therapies have gained significant traction in the recent years owing to their potential to treat various genetic diseases. RNA interference and antisense technologies have enabled development of novel therapeutics for diseases previously considered untreatable. Increasing investment by governments and private organizations is a major factor driving growth of the global RNA therapeutics.

North America currently dominates due to presence of major players and availability of advanced healthcare facilities. However, Asia Pacific is expected to witness fastest growth during the forecast period. Growing burden of genetic disorders, rising healthcare expenditure, and improving regulatory guidelines are factors expected to boost the APAC RNA therapeutics.

RNA therapeutics - https://www.coherentmi.com/blog/rna-therapeutics-poised-to-accelerate-during-the-forecast-period-owing-to-increasing-focus-on-ribonucleic-acid-based-medicines-127